Bioventures Investors
SEC exempt reporting adviser (venture capital exemption).
- HQ
- MA
Bioventures Investors is a venture firm that invests in MedTech companies at early and growth stages, providing capital, expertise, and support to portfolio companies. It focuses on companies seeking growth capital. Marc Goldberg is listed as co-founder and managing partner, alongside several managing directors and venture partners. Listed portfolio companies include Optivio, Endotronix, and Verax Biomedical.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series A, Series B |
| Sectors | Medical devices | Not enough dated deals | Biotech, Healthtech, Medical devices |
| Regions | Not stated | Not enough dated deals | MA, CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2000 | 1 | Biotech, Enterprise SaaS, Hardware |
| 2002 | 4 | Biotech, Healthtech, Medical devices |
| 2003 | 3 | Biotech, Healthtech, Medical devices |
| 2004 | 3 | Biotech, Healthtech, Life sciences and research tools |
| 2005 | 2 | Biotech, Healthtech |
| 2006 | 1 | Biotech, Data analytics, Healthtech |
| 2007 | 7 | Healthtech, Biotech, Medical devices |
| 2008 | 2 | Biotech, Healthtech, Life sciences and research tools |
| 2009 | 2 | Biotech, Healthtech, Life sciences and research tools |
| 2010 | 1 | Biotech, Healthtech |
| 2015 | 1 | Hardware, Manufacturing |
| 2016 | 1 | Biotech, Healthtech, Medical devices |
| 2017 | 1 | Healthtech, Medical devices |
| 2018 | 2 | Biotech, Healthtech, Medical devices |
| 2019 | 1 | Medical devices |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP | 2020 | $204.5M to $350M (Form D) | Follow-ons only |
03 · People across funds
- James Lousararian, Managing Director of the Issuer's General Partner.
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP (Named on Form D)
- Jeffrey Barnes, Managing Director of the Issuer's General Partner.
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP (Named on Form D)
- Jonathan Gertler, Managing Director of the Issuer's General Partner.
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP (Named on Form D)
- Marc Goldberg, Managing Director of the Issuer's General Partner.
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP (Named on Form D)
- Charles Bridges, ADVISORY BOARD
- Chris Thompson, KEYSTONE PARTNER
- Donna Edmonds, ADVISORY BOARD
- John E. Osborn, VENTURE PARTNER AND PRINCIPAL
- Jonathan Cohen, KEYSTONE PARTNER
- Jonathan P. Gertler, MANAGING DIRECTOR
- Laura Niklason, ADVISORY BOARD
- Peter Feinstein, CO-FOUNDER AND VENTURE PARTNER
- Stephen Liu, VENTURE PARTNER
- Tom Buttacavoli, MANAGING DIRECTOR
- Tony Lyons, MANAGING DIRECTOR - INVESTOR DEVELOPMENT
- Walter Gilbert, VENTURE PARTNER
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.BIOVENTURESINVESTORS.COM
- https://www.bioventuresinvestors.com/
- https://www.bioventuresinvestors.com/investment-team
- https://www.bioventuresinvestors.com/investment-portfolio
- https://www.bioventuresinvestors.com/investment-strategy
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026